David W. Johnson

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1

Kimberly A. McAllister, K.M. Grogg, David W. Johnson et al. · Nature Genetics · 1994 · 1.5K citations · Full text

Endothelial Cell Pathobiology, Vascular Disease, Developmental Biology +10

Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2

David W. Johnson, Jonathan Berg, Melanie A. Baldwin et al. · Nature Genetics · 1996 · 1.1K citations

Activin Receptor–like, Developmental Biology, Signal Transduction +7

Climate Impact of Increasing Atmospheric Carbon Dioxide

James E. Hansen, David W. Johnson, Andrew A. Lacis et al. · Science · 1981 · 1.1K citations

Future Climatic Change, Engineering, Greenhouse Gas Emission +16

Peritoneal Dialysis-Related Infections Recommendations: 2010 Update

Philip Kam‐Tao Li, Cheuk‐Chun Szeto, Beth Piraino et al. · Peritoneal Dialysis International · 2010 · 891 citations · Full text

Hemodialysis, Medicine, Dialysis Therapy +3